Trepmac

Trepmac uses and dosage

Trepmac (Brigatinib), generic Alunbrig is a prescription medicine used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Trepmac manufactured by Genvio Pharma Ltd. in Bangladesh. Brigatinib has to take orally once a day with or without food. After the first 7 days if tolerated, healthcare provider may increase dose to 180 mg orally once daily.

Trepmac side effects

The most common adverse reactions of Brigatinib are: Nausea / vomiting, diarrhea, decreased appetite, abdominal pain, constipation, tiredness, dizziness, fever, headache, trouble sleeping, or joint pain.

Originator brand

Alunbrig by ARIAD Pharmaceuticals

Made by

Genvio Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.